In fact, in addition to direct effects on differentiation of MDS cells, in vivo TLR7/8-mediated activation of other immune cells could induce cell-mediated immune responses to tumour cells, also contributing to enhance their therapeutic effect43,44. The gene discussed is TLR7; the disease is myelodysplastic syndrome.